Qualigen Therapeutics Inc...

NASDAQ: QLGN · Real-Time Price · USD
1.89
0.13 (7.14%)
At close: Aug 15, 2025, 3:59 PM
1.91
1.06%
After-hours: Aug 15, 2025, 06:37 PM EDT

Qualigen Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-6.97M -6.36M -7.77M -8.37M -10.4M -12.48M -18.54M -20.2M -20.82M -21.03M -18.56M -17.37M -18.54M -17.9M -4.69M -9.95M -23.22M
Depreciation & Amortization
73.61K n/a 4.5K -234.59K -111.81K 4.5K 109.99K 438.63K 407.66K 375.6K 354.83K 350.88K 340.89K 338.28K 330.28K 323.67K 324.73K
Stock-Based Compensation
69.68K 128.06K 188.64K 284.13K 904.96K 1.1M 2.41M 3.7M 4.47M 5.48M 5.53M 5.44M 5.3M 5.29M 5.09M 4.99M 4.06M
Other Working Capital
-389.62K -338.44K 466.87K 1.04M 284.84K -445.84K 94.56K 79.41K -660.26K -1.18M -1.42M -1.42M -942.66K 1.68M 556.86K -932.66K -790.4K
Other Non-Cash Items
146.45K 1.17M -2.78M 2.43K 563.02K 109.87K 8.6M 5.02M 4.74M 3.36M 405.49K -1.31M -3.46M -2.59M -14.36M -8.19M 10.13M
Deferred Income Tax
n/a n/a 572.47K 422.1K 11.44K -153.73K -726.2K -575.83K -165.17K n/a n/a n/a n/a -2.08M -2.08M -2.08M -2.08M
Change in Working Capital
-450.44K -783.58K 533.48K 1.38M 1.06M 1.11M 1.28M 639.85K -630.62K -1.43M -1.65M -878.03K -163.51K 2.21M 438.18K -1.86M -1.46M
Operating Cash Flow
-7.13M -6.33M -9.73M -7M -8.45M -10.3M -6.87M -10.98M -12M -13.25M -13.92M -13.77M -16.53M -14.73M -15.27M -16.76M -12.24M
Capital Expenditures
2.00 2.00 2.00 246.42K 198.01K n/a -244.37K -502.05K -467.5K -319.12K -91.75K -90.16K -121.99K -141.36K -196.6K -373.92K -725.92K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -135.35K -135.35K n/a n/a 135.35K 135.35K n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 8.82M 8.82M 8.82M 8.82M n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-2.21M -1.91M -664.6K 4.57M 4.22M 4.02M 3.92M -73.91K -73.91K 124.09K -8.83M -8.82M -8.82M -8.83M 585.09K 425.63K 136.63K
Investing Cash Flow
-2.21M -1.91M -664.6K 4.81M 4.41M 4.22M 3.74M -502.05K -332.15K -183.76K 43.6K 45.2K -121.99K -141.36K 395.22K 217.91K -134.1K
Debt Repayment
500.98K 975.98K 1.48M 1.03M 35K -440K 2.46M 2.9M 2.9M 2.9M n/a n/a -15.61K 1.25M 965.9K 1.61M 2.43M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-87.6K -87.6K -87.6K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
5.55M 4.8M 127.6K 40K -110K -110K -505 2.81K 2.81K 6.67K -664.02K -537.91K -488.18K -1.64M 11.77M 27.78M 33.15M
Financial Cash Flow
9.28M 9.01M 4.83M 1.07M -75K -550K 2.46M 2.91M 2.91M 2.91M 8.16M 8.28M 8.32M 8.43M 12.73M 29.39M 34.17M
Net Cash Flow
-63.01K 1.22M -1.24M -778.41K -3.83M -6.64M -4.55M -8.4M -9.24M -10.5M -5.7M -5.48M -8.34M -6.44M -25.97M -10.97M -2.03M
Free Cash Flow
-7.13M -6.33M -9.73M -6.75M -8.26M -10.3M -7.11M -11.48M -12.47M -13.57M -14.01M -13.86M -16.65M -14.87M -15.47M -17.13M -12.97M